PureTech Health plc
A clinical-stage biotherapeutics company developing new medicines for devastating diseases.
PRTC | IL
Overview
Corporate Details
- ISIN(s):
- GB00BPVG5C82 (+2 more)
- LEI:
- 213800LVPDNO2Z9T9I39
- Country:
- United States of America
- Address:
- 6 TIDE STREET, 2210 BOSTON
- Website:
- https://puretechhealth.com/
- Sector:
- Manufacturing
Description
PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-10-05 13:00 |
Alivio Awarded $3.3M from DoD to Advance ALV-304
|
English | 20.0 KB | ||
| 2020-10-01 08:05 |
PureTech Appoints Biocon Founder Kiran Shaw to BOD
|
English | 16.4 KB | ||
| 2020-10-01 08:00 |
Total Voting Rights
|
English | 9.7 KB | ||
| 2020-09-30 15:00 |
BARDA Awards Vedanta Up to $76.9M to Advance VE303
|
English | 22.1 KB | ||
| 2020-09-29 13:00 |
Alivio Adds Dr Harry Leider to Board of Directors
|
English | 20.5 KB | ||
| 2020-09-25 17:35 |
Price Monitoring Extension
|
English | 2.8 KB | ||
| 2020-09-23 08:00 |
PureTech Nasdaq Listing Progresses
|
English | 9.8 KB | ||
| 2020-09-18 17:41 |
Second Price Monitoring Extn
|
English | 2.8 KB | ||
| 2020-09-18 17:35 |
Price Monitoring Extension
|
English | 2.8 KB | ||
| 2020-09-18 11:15 |
Price Monitoring Extension
|
English | 2.8 KB | ||
| 2020-09-16 14:00 |
Vedanta Appoints Drug Development Leader as CMO
|
English | 20.9 KB | ||
| 2020-09-04 13:42 |
Gelesis Presents Plenity Efficacy and Safety Data
|
English | 26.9 KB | ||
| 2020-09-04 13:07 |
Second Price Monitoring Extn
|
English | 2.8 KB | ||
| 2020-09-04 13:02 |
Price Monitoring Extension
|
English | 2.8 KB | ||
| 2020-09-03 13:02 |
Price Monitoring Extension
|
English | 2.8 KB |
Automate Your Workflow. Get a real-time feed of all PureTech Health plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PureTech Health plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PureTech Health plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
